---
title: "Spherical Aberration and Contrast Sensitivity Function in Eyes Implanted With Spherical and Aspheric Intraocular Lenses: A Clinical Trial"
nct_id: NCT01028872
overall_status: COMPLETED
phase: PHASE4
sponsor: Shahid Beheshti University of Medical Sciences
study_type: INTERVENTIONAL
primary_condition: Cataract
countries: Iran
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01028872.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01028872"
ct_last_update_post_date: 2009-12-09
last_seen_at: "2026-05-12T06:26:35.213Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Spherical Aberration and Contrast Sensitivity Function in Eyes Implanted With Spherical and Aspheric Intraocular Lenses: A Clinical Trial

**NCT ID:** [NCT01028872](https://clinicaltrials.gov/study/NCT01028872)

## Key Facts

- **Status:** COMPLETED
- **Phase:** PHASE4
- **Study Type:** INTERVENTIONAL
- **Lead Sponsor:** Shahid Beheshti University of Medical Sciences
- **Conditions:** Cataract
- **CT.gov Last Update:** 2009-12-09

## Brief Summary

Aspheric intraocular lenses can effectively reduce higher-order aberrations and improve contrast sensitivity function after cataract surgery.

## Eligibility

- **Minimum age:** 55 Years
- **Maximum age:** 75 Years
- **Sex:** ALL

```
Inclusion Criteria:

* Senile cataract

Exclusion Criteria:

* Glaucoma, corneal opacity, retinal abnormality, previous history
```

## Arms

- **Sensar IOL** (SHAM_COMPARATOR)
- **Tecnis IOL** (ACTIVE_COMPARATOR)
- **AcrySof IQ** (ACTIVE_COMPARATOR)

## Interventions

- **Intraocular lens** (DEVICE)
- **Intraocular lens** (DEVICE)
- **Intraocular lens** (DEVICE)

## Locations (1)

- Labbafinejad Medical Center, Tehran, Iran

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.labbafinejad medical center|tehran||iran` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01028872.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01028872*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*